BMC Cancer (Nov 2012)

Germline truncating-mutations in <it>BRCA1</it> and <it>MSH6</it> in a patient with early onset endometrial cancer

  • Kast Karin,
  • Neuhann Teresa M,
  • Görgens Heike,
  • Becker Kerstin,
  • Keller Katja,
  • Klink Barbara,
  • Aust Daniela,
  • Distler Wolfgang,
  • Schröck Evelin,
  • Schackert Hans K

DOI
https://doi.org/10.1186/1471-2407-12-531
Journal volume & issue
Vol. 12, no. 1
p. 531

Abstract

Read online

Abstract Background Hereditary Breast and Ovarian Cancer Syndrome (HBOCS) and Hereditary Non-Polyposis Colorectal Cancer Syndrome (HNPCC, Lynch Syndrome) are two tumor predisposition syndromes responsible for the majority of hereditary breast and colorectal cancers. Carriers of both germline mutations in breast cancer genes BRCA1 or BRCA2 and in mismatch repair (MMR) genes MLH1, MSH2, MSH6 or PMS2 are very rare. Case presentation We identified germline mutations in BRCA1 and in MSH6 in a patient with increased risk for HBOC diagnosed with endometrial cancer at the age of 46 years. Conclusions Although carriers of mutations in both MMR and BRCA genes are rare in Caucasian populations and anamnestical and histopathological findings may guide clinicians to identify these families, both syndromes can only be diagnosed through a complete gene analysis of the respective genes.